5-METHOXY-7-(TRIFLUOROMETHYL)PYRAZOLO[1,5-A]PYRIDINE-2-CARBOXYLIC ACID, 97.0%, 100mg

Sample vials with short thread ND9 Vial kit, HPLC-certified, Brown glass, with labelling space, 1 Set

2-Hydroxy-6-iodobenzaldehyde, 98%, 1g

(+)-Longifolene, 90%, 5g

1-Cyclobutyl-1H-pyrazol-5-amine, 97%, 1g

PRAMIRACETAM, 98%, 5g

3-(4-Chloro-1-ethyl-1H-pyrazol-3-yl)-3-oxo-propionic acid methyl ester, 250mg

3-cyclopropyl-1-phenyl-1H-pyrazole-5-carboxylic acid, 95.0%, 1g

N,3-DIMETHYL-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZAMIDE, 95%, 5g

L-Ribose>98.0%(HPLC)25g

4-(2-((4-Aminophenethyl)(methyl)amino)ethoxy)aniline, 98%, 10g

Ethyl 2,3-difluoropyridine-4-carboxylate, 5g

6-Chloro-[1,2,4]triazolo[4,3-b]pyridazin-3-amine, 97%, 100mg